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ABSTRACT 
 
The role of ABC transporters in clinical practice 
ATP-binding cassette (ABC) transporters are a family of transporter proteins that 
contribute to drug resistance via ATP-dependent drug efflux pumps.  There are seven 
subfamilies classified as ABC transporters (ABCA through ABCG) that are expressed in 
both normal and malignant cells. They are involved in the transport of many substances, 
including the excretion of toxins from the liver, kidneys, and gastrointestinal tract, and 
they limit permeation of toxins to vital structures, such as the brain, placenta, and testis. 
The best-characterized transporter protein is MDR1/P-glycoprotein, and a number of 
clinical investigations have suggested that its intrinsic or acquired overexpression 
resulted in a poor clinical outcome of chemotherapy. Conventional cancer 
chemotherapy is seriously limited by the multidrug resistance (MDR) commonly 
exhibited by tumour cells. One mechanism by which a living cell can achieve multiple 
resistances is via the active efflux of a broad range of anticancer drugs through the 
cellular membrane. Various types of compounds and techniques for the reversal of ABC 
transporters mediated MDR have been developed, and efforts have concentrated on the 
inhibition of function and suppression of expression. Increased drug accumulation and 
drug resistance reversal with P-gp inhibitors have been well documented in vitro, but 
only suggested in clinical trials.  
 
 
 
